Prolia is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture. Use a 27gauge needle to withdraw and inject the entire contents of the vial. Prolia and xgeva are not considered medically necessary for indications other than those listed above due to insufficient evidence of therapeutic value. Information for the patient xgeva 120 mg solution for injection denosumab read all of this leaflet carefully before you start using this medicine because it contains important information for. Highlights of prescribing information procrit epoetin alfa.
Information for the user prolia 60 mg solution for injection in prefilled syringe denosumab read all of this leaflet carefully before you start using this medicine because it contains important information for you. Denosumab prolia, xgeva related to lcd l33394 a52399. Highlights of prescribing information these highlights do not include all the information needed to use reclast safely and effectively. May worsen, especially in patients with renal impairment. Xgeva is a clear, colorless to pale yellow solution that may contain trace amounts of translucent to white proteinaceous particles. For subsequent monthly doses for both of the above scenarios, instruct patients to return to their original schedule by taking one boniva 150 mg tablet every month on their previous chosen day. Learn about a medicine used to help prevent serious bone problems in patients with multiple myeloma or from solid tumors.
If you have any further questions, ask your doctor, pharmacist, or nurse. Visually inspect xgeva for particulate matter and discoloration prior to administration. Highlights of prescribing information these highlights do not include all the information needed to use prolia safely and effectively. Monitor calcium levels, throughout xgeva therapy, especially in the first weeks of initiating therapy, and administer calcium, magnesium, and vitamin d as necessary. Information for the patient xgeva 120 mg solution for injection denosumab read all of this leaflet carefully before you start using this medicine because it contains important information for you. Specialty guideline management xgeva denosumab policy. Shared care arrangement and prescribing information for. Xgeva 3 level of xgeva wasand were previously authorized by hmsacvs and members demonstrate a response to xgeva therapy defined as albumincorrected serum calcium level of xgeva should be administered under the responsibility of a healthcare professional. Perform an oral examination prior to starting xgeva. Xgeva is not indicated for the prevention of skeletalrelated events in patients with multiple myeloma see clinical trials 14. If the next scheduled boniva day is only 1 to 7 days away, wait until the subsequent months scheduled boniva day to take their tablet. Sca and prescribing information for denosumab 120mg injection xgeva.
Xgeva is indicated for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy. Prescription treatment with zytiga abiraterone acetate. For prevention of skeletal related events in patients with bone. Infusion reactions andcardiopulmonary arrest see full prescribing information for complete boxed warning. Discontinue permanently if a clinically significant reaction occurs 5. Xgeva is a clear, colorless to pale yellow solution that may contain trace amounts of translucent to. The indications below including fdaapproved indications and compendial uses are considered a covered benefit provided that all the approval. Highlights of prescribing information these highlights do not include all theinformation needed to use xgevasafely and effectively. Insert needle and inject all the liquid subcutaneously. Xgeva is indicated for the prevention of skeletalrelated events in patients with bone metastases from solid tumors. Xgevadenosumab injection, for subcutaneous use initial usapproval. Monitor calcium levels during therapy, especially in the first weeks of initiating therapy, and adequately supplement all patients with calcium and vitamin d 5. View important safety information and full prescribing information on.
Xgeva is a sterile, preservativefree, clear, colorless to pale yellow solution. Read all of this leaflet carefully before you start using this medicine. Prolia denosumab injection, for subcutaneous use initial u. This solution is readytouse and may be administered directly to the patient without further preparation. Clinical reasons to avoid iv bisphosphonate therapy renal insufficiency creatinine clearance desmopressin acetate 4 mcgml has infrequently produced changes in blood pressure causing either a slight elev ation in blood pressure or a transient fall in blood pressure and a compensatory increase in heart rate. Erbitux can cause serious and fatal infusion reactions. Page 1 highlights of prescribing information these.
Attach the adapter to the powder vial by pressing the adapter down until the spike pushes through the rubber stopper and the adapter snaps in place see figure a. Prepare the prefilled syringe by attaching the plunger. Denosumab has an approximate molecular weight of 147 kda and is produced in genetically engineered mammalian chinese hamster ovary cells. Escherichia coli, klebsiella pneumoniae, citrobacter. Information for the user prolia 60 mg solution for injection in prefilled syringe denosumab read all of this leaflet carefully before you start using this medicine because it contains. The infusion time must not be less than 15 minutes given over a constant infusion rate. Zytiga abiraterone acetate is a prescription medicine that is used along with prednisone. Xgeva fda prescribing information, side effects and uses. To prepare reduced doses for patients with baseline crcl less than or equal to 60 mlmin, withdraw the. The drug should be used with caution in patients with coronary. Highlights of prescribing information hypocalcemia. Indications the indications below including fdaapproved indications and compendial uses are considered a covered benefit. If you have any further questions, ask your doctor or pharmacist.
Serious bone problem prevention xgeva denosumab injection. Xgeva product monograph page 4 of 63 pediatrics the safety and efficacy of xgeva have not been studied in pediatric populations other than skeletally mature adolescents aged 17 years with giant. Xgeva is indicated for the prevention of skeletalrelated events in patients with multiple myeloma and in patients with bone metastases from solid tumors. Indications the indications below including fdaapproved indications and compendial uses are considered a covered benefit provided that all the approval criteria are met and the member has no exclusions to the prescribed therapy. Xgeva denosumab is a human igg2 monoclonal antibody that binds to human rankl. Do not pull the back stopper flange off of the syringe. Xgeva is indicated for treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity. Erbituxcetuximabinjection,for intravenous use initial u.
Insert the plunger rod into the prefilled syringe containing sterile water, usp, and screw the plunger rod clockwise to tighten. Adequately supplement patients with calcium and vitamin d 5. For subsequent monthly doses for both of the above scenarios. Patients treated with xgeva should be given the package leaflet and the patient reminder card. Prevention of skeletal related events in adults with advanced. May 09, 2019 visually inspect xgeva for particulate matter and discoloration prior to administration. Page 3 of 44 full prescribing information 1 indications and usage 1.
You will only feel light resistance when screwing the plunger rod into position. Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for prolia denosumab skip to. Highlights of prescribing information adequately rehydrate. Highlights of prescribing information hypocalcemia may worsen. Refer to the full prescribing information ofcoadministeredpalbociclib,abemaciclib,or ribociclibfor dose modification guidelines in the eventof toxicities, for use with concomitant medications, and other relevant safety information. Do not use if the solution is discolored or cloudy or if the solution contains many particles or foreign particulate matter. Posology supplementation of at least 500mgcalcium and 400iu vitamin d daily is required in all patients, unless hypercalcaemia is presentsee section 4. Xgeva injection for subcutaneous use prescribing information. Zytiga is used to treat men with prostate cancer that has spread to other parts of the body. Xerava is indicated for the treatment of complicated intraabdominal infections ciai caused by susceptible microorganisms.
1585 549 234 166 1291 180 1068 37 206 749 799 750 1132 1586 1568 1112 1101 623 1362 444 1276 1566 725 729 680 734 823 423 1157 552 1243 981 1405 1499 53 1021 1394 330 1033 254 11